Cargando…
Molecular docking analysis of HER-2 inhibitor from the ZINC database as anticancer agents
The human epidermal growth factor (HER2) is a transmembrane receptor that is highly expressed in breast cancer and in different other cancers. Therefore, it is of interest to identify the new HER2 inhibitors from a selected 300 compounds in the ZINC database. The top two hit compounds (ZINC000014780...
Autores principales: | Sait, Khalid Hussain Wali, Mashraqi, Mutaib, Khogeer, Asim Abdulaziz, Alzahrani, Othman, Anfinan, Nisreen M, Sait, Hesham Khalid, Almutairi, Abdulrahman, Alam, Qamre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Biomedical Informatics
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573456/ https://www.ncbi.nlm.nih.gov/pubmed/34803263 http://dx.doi.org/10.6026/97320630016882 |
Ejemplares similares
-
Structure-based virtual screening and molecular docking for the identification of potential novel EGFRkinase inhibitors against ovarian cancer
por: Sait, Khalid Hussain Wali, et al.
Publicado: (2019) -
MDR1 Gene Polymorphisms and Its Association With Expression as a Clinical Relevance in Terms of Response to Chemotherapy and Prognosis in Ovarian Cancer
por: Haque, Absarul, et al.
Publicado: (2020) -
Overall and progression-free survival in endometrial carcinoma: A single-center retrospective study of patients treated between 2000-2018
por: Sait, Khalid H., et al.
Publicado: (2023) -
Indicators of survival and prognostic factors in women treated for cervical cancer at a tertiary care center in Saudi Arabia
por: Anfinan, Nisreen, et al.
Publicado: (2020) -
Survival and prognostic factors in women treated for epithelial ovarian cancer in western region of Saudi Arabia
por: Sait, Khalid H., et al.
Publicado: (2022)